Antibody response of patients with Helicobacter pylori-related gastric adenocarcinoma: Significance of anti-CagA antibodies

Clinical and Diagnostic Laboratory Immunology

Volumn 7, Issue 3, 2000, Pages 463-467

  Vaucher, Christine ^a   Janvier, Blandine ^b   Nousbaum, Jean Baptiste ^c   Grignon, Bernadette ^b   Pezennec, Leon ^b   Robaszkiewicz, Michel ^c   Gouerou, Herve ^c   Picard, Bertrand ^a   Fauchere, Jean Louis ^b  

^a FACULTÉ DE MÉDECINE ET DES SCIENCES DE LA SANTÉ   (France)

^b POITIERS UNIVERSITY HOSPITAL   (France)

^c SERVICE DE RHUMATOLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; CAGA ANTIBODY; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ADULT; AGED; ANTIBODY RESPONSE; ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GASTRODUODENAL ULCER; HELICOBACTER PYLORI; HUMAN; IMMUNOBLOTTING; LATEX AGGLUTINATION TEST; MALE; PRIORITY JOURNAL; SERUM; STOMACH ADENOCARCINOMA;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; DUODENAL ULCER; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOBLOTTING; MALE; MIDDLE AGED; SEROLOGIC TESTS; STOMACH NEOPLASMS;

EID: 0034103014     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.7.3.463-467.2000     Document Type: Article

References (50)

1. Asaka, M., M. Kudo, M. Kato, T. Sugiyama, and H. Takeda. 1998. Long term Helicobacter pylori infection from gastritis to gastric cancer. Aliment. Pharmacol. Ther. 12:9-15.
2. Atherton, J. C., P. Cao, R. M. Peek, Jr., M. K. Tummuru, M. J. Blaser, and T. L. Cover. 1995. Mosaicism in vacuolation cytotoxin alleles of Helicobacter pylori. Association of vacA types with cytotoxin production and peptic ulceration. J. Biol. Chem. 270:17771-17777.
3. Aucher, P., M. L. Petit, P. R. Mannant, L. Pezennec, P. Babin, and J. L. Fauchère. 1998. Use of immunoblot assay to define serum antibody patterns associated with Helicobacter pylori infection and with H. pylori-related ulcers. J. Clin. Microbiol. 36:931-936.
4. Baron, J. H., and R. P. H. Logan. 1994. Infection by Helicobacter pylori is the major cause of duodenal ulcer. Proc. R. Coll. Physicians Edinb. 24:21-36.
5. Basso, D., F. Navaglia, L. Brigato, M. G. Piva, A. Toma, E. Greco, F. Di Mario, F. Galeotti, G. Roveroni, A. Corsini, and M. Plebani. 1998. Analysis of Helicobacter pylori vacA and cagA genotypes and serum antibody profile in benign and malignant gastroduodenal diseases. Gut 43:182-186.
6. Bazillou, M., C. Fendri, O. Castel, P. Ingrand, and J. L. Fauchère. 1994. Serum antibody response to the superficial and released components of Helicobacter pylori. Clin. Diagn. Lab. Immunol. 1:310-317.
7. Blaser, M. J., P. H. Chyou, and A. Nomura. 1995. Age at establishment of Helicobacter pylori infection and gastric carcinoma, gastric ulcer, and duodenal ulcer risk. Cancer Res. 55:562-565.
8. Blaser, M. J., G. I. Perez-Perez, H. Kleanthous, T. L. Cover, R. M. Peek, P. H. Chyou, G. N. Stermmermann, and A. Nomura. 1995. Infection with strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res. 55:2111-2115.
9. Censini, S., C. Lange, Z. Xiang, J. Crabtree, P. Ghiara, M. Borodovsky, R. Rappuoli, and A. Covacci. 1996. cagA, a pathogenicity island of Helicobacter pylori, encodes type-1 specific and disease-associated virulence factors. Proc. Natl. Acad. Sci. USA 93:14648-14653.
10. Craanen, M. E., P. Blok, W. Dekker, and G. N. J. Tytgat. 1994. Helicobacter pylori and early gastric cancer. Gut 35:1372-1374.
11. Crabtee, J. E., J. I. Wyatt, G. M. Sobala, G. Miller, D. S. Tompkins, J. N. Primrose, and A. G. Morgan. 1993. Systemic and mucosal humoral responses to Helicobacter pylori in gastric cancer. Gut 34:1339-1343.
12. Doig, P., J. W. Austin, and T. J. Trust. 1993. The Helicabacter pylori 19.6-kilodalton protein is an iron-containing protein resembling ferritin. J. Bacteriol. 175:557-560.
13. Eurogast Study Group. 1993. An international association between Helicobacter pylori and gastric cancer. Lancet 341:1359-1362.
14. Eurogast Study Group. 1993. Epidemiology of, and risk factors for, Helicobacter pylori infection among 3194 asymptomatic subjects in 17 populations. Gut 34:1672-1676.
15. Faulde, M., J. P. Schrôder, and D. Sobe. 1992. Serodiagnosis of Helicobacter pylori infections by detection of immunoglobulin G antibodies using an immunoblot technique and enzyme immunoassay. Eur. J. Clin. Microbiol. Infect. Dis. 11:589-594.
16. Forman, D., D. G. Newell, F. Fullerton, J. G. W. Yarnell, A. R. Stacey, N. Wald, and F. Sitas. 1991. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. BMJ 302:1302-1305.
17. Frazier, B. A., J. D. Pfeifer, D. G. Russel, P. Falk, A. N. Olsen, M. Hammar, T. U. Westblom, and S. J. Normark. 1993. Paracrystalline inclusions of a novel ferritin containing nonheme iron, produced by the human gastric pathogen Helicobacter pylori: evidence for a third class of ferritins. J. Bacteriol. 175:966-972.
18. Graham, D. Y. 1991. Helicobacter pylori: its epidemiology and its role in duodenal ulcer disease. J. Gastroenterol. Hepatol. 6:105-113.
19. Greenacre, M. J. 1984. Theory and applications of correspondences, p. 364. Academic Press, London, England.
20. Hansson, L. E., L. Engstrand, O. Nyren, D. J. Evans, A. Lindgren, R. Bergstrôm, B. Anderson, L. Athlin, O. Bendtsen, and P. Tracz. 1993. Helicobacter pylori infection: independent risk factor of gastric adenocarcinoma. Gastroenterology 105:1098-1103.
21. Honda, S., T. Fujioka, M. Tokieda, R. Satoh, A. Nishizono, and M. Nasu. 1998. Development of Helicobacter pylori-induced gastric carcinoma in Mongolian gerbils. Cancer Res. 58:4255-4259.
22. Huang, J. Q., S. Sridhar, Y. Chen, and R. H. Hunt. 1998. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 114:1169-1179.
23. Jensen, A. K. V., L. P. Andersen, and C. H. Wachman. 1993. Evaluation of eight commercial kits for Helicobacter pylori IgG antibody detection. APMIS 101:795-801.
24. Joossens, J., and J, Geboers. 1984. Diet and environment in the etiology of gastric cancer, p. 168-183. In B. Levin and R. H. Riddel (ed.), Frontiers in gastrointestinal cancer. Elsevier, New York, N.Y.
25. Klaamas, K., M. Held, T. Wadstrôm, A. Lipping, and O. Kurtenkov. 1996. IgG immune response to Helicobacter pylori antigens in patients with gastric cancer as defined by elisa and immunoblotting. Int. J. Cancer 67:1-5.
26. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
27. Lauren, P. 1965. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Pathol. Microbiol. Scand. 64: 31-49.
28. Lebart, L., A. Morineau, and K. M. Warwick. 1984. Multivariate descriptive analysis and related techniques for large matrices. Wiley Interscience. New York, N.Y.
29. Midolo, P. D., J. R. Lambert, E. G. Russel, and S. K. Lin. 1995. A practical single sample dry latex agglutination test for Helicobacter pylori antibody detection. J. Clin. Pathol. 48:969-971.
30. Mitchell, H. A., S. L. Hazell, T. Kolesnikow, J. Mitchell, and D. Frommer. 1996. Antigen recognition during progression from acute to chronic infection with a cagA-positive strain of Helicobacter pylori. Infect. Immun. 64:1166-1172.
31. Nilsson, I., A. Ljungh, P. Aleljung, and T. Wadstrôm. 1997. Immunoblot assay for serodiagnosis of Helicobacter pylori infections. J. Clin. Microbiol. 35:427-432.
32. Parkin, P., P. Pisani, and J. Ferlay. 1995. Estimates of the worldwide incidence of eighteen major cancers in 1993. Int. J. Cancer 54:594-606.
33. Parsonnet, J., G. D. Friedman, D. P. Vandersteen, Y. Chang, J. H. Vogelman, N. Orentreich, and R. K. Sibley. 1991. Helicobacter pylori infection and the risk of gastric carcinoma. N. Engl. J. Med. 325:1127-1131.
34. Parsonnet, J., D. Vandersteen, J. Goates, R. K. Sibley, J. Pritikin, and Y. Chang. 1991. Helicobacter pylori infection in intestinal and diffuse type gastric adcnocarcinomas. J. Natl. Cancer Inst. 83:640-643.
35. Pronovost, A. D., S. L. Rose, J. W. Pawlak, H. Robin, and R. Schneider. 1994. Evaluation of a new immunodiagnostic assay for Helicobacter pylori antibody detection: correlation with histopathological and microbiological results. J. Clin. Microbiol. 32:46-50.
36. Rudi, J., C. Kolb, M. Maiwald, D. Kuck, A. Sieg, P. R. Galle, and W. Stremmel. 1998. Diversity of Helicobacter pylori vacA and cagA genes and relationship to VacA and CagA protein expression, cytotoxin production, and associated diseases. J. Clin. Microbiol. 36:944-948.
37. Rudi, J., C. Kolb, M. Maiwald, I. Zuna, A. von Herbay, P. R. Galle, and W. Stremmel. 1997. Serum antibodies against Helicobacter pylori proteins VacA and CagA arc associated with increased risk for gastric cancer. Dig. Dis. Sci. 42:1652-1659.
38. Salaün, L., C. Audibert, G. Le Lay, C. Burucoa, J. L. Fauchere, and B. Picard. 1998. Panmictic structure of Helicobacter pylori demonstrated by the comparative study of six genetic markers. FEMS Microbiol. Lett. 161:231-239.
39. Shimoyama, T., S. Fukuda, M. Tanaka, T. Mikami, A. Munakata, and J. E. Crabtree. 1998. CagA seropositivity associated with development of gastric cancer in a Japanese population. J. Clin. Pathol. 51:225-228.
40. Siman, J. H., A. Forsgren, G. Berglund, and C. H. Floren. 1997. Association between Helicobacter pylori and gastric cancer in the city of Malmö, Sweden. Scand. J. Gastroenterol. 32:1215-1221.
41. Talley, N. J., A. R. Zinsmeister, A. Weaver, E. P. Dimagno, H. A. Carpenter, G. I. Perez-Perez, and M. J. Blaser. 1991. Gastric adenocarcinoma and Helicobacter pylori infection. J. Natl. Cancer Inst. 83:1734-1739.
42. Tenehaus, M., and F. W. Young. 1985. An analysis and synthesis of multiple correspondence analysis, optimal scaling, dual scaling, homogeneity analysis, and other methods for quantifying categorical multivariate data. Psychometrika 50:91-119.
43. Vaira, D., J. Holton, M. Menegatti, F. Landi, C. Ricci, A. Ali, F. Landi, C. Moretti, and M. Miglioli. 1998. Blood tests in the management of Helicobacter pylori infection. Gut 43(Suppl. 1):S39-S46.
44. Van Doorn, L. J., C. Figueiredo, R. Sanna, A. Plaisier, P. Schneeberger, W. de Boer, and W. Quint. 1998. Clinical relevance of the cagA, vacA and iceA status of Helicobacter pylori. Gastroenterology 115:58-66.
45. Wang, T. C., and J. G. Fox. 1998. Helicobacter pylori and gastric cancer: Koch's postulates fullfilled? Gastroenterology 115:780-783.
46. Warren, J. B., and B. Marshall. 1983. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1:1273-1275.
47. Watanabe, T., M. Tada, H. Nagai, S. Sasaki, and M. Nakao. 1998. Helicobacter pylori infection induces gastric cancer in mongolian gerbils. Gastroenterology 115:642-648.
48. Webb, P. M., D. Forman, D. Newell, A. Covacci, and J. E. Crabtree. 1996. European Study Group. An international association between prevalence of infection with cagA positive strains of H. pylori and mortality from gastric cancer. Gut 39(Suppl. 2):A1.
49. Weel, J. F. L., R. W. M. van der Hulst, Y. Gerrits, P. Roorda, M. Feller, J. Dankert, G. N. Tytgat, and A. van der Ende. 1996. The relationship between cytotoxin-associated gene A, vacuolating cytotoxin, and Helicobacter pylori-related diseases. J. Infect. Dis. 173:1171-1175.
50. Whiting, J. L., M. T. Hallissey, J. W. L. Fielding, and J. Dunn. 1998. Screening for gastric cancer by Helicobacter pylori serology: a retrospective study. Br. J. Surg. 85:408-411.